Video: A Whole Family Approach to HBV Prevention, Rangsima Lolekha, MD

International Viral Hepatitis Elimination Meeting (IVHEM) 2021

Video: Liver Cancer in Sub-Saharan Africa - Lewis Roberts, MB, Chb, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2021

The Role of Modeling: Strengths and Limitations, Jag Chhatwal, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2021

Example Monitoring  Implementation; Tracking Progress and Progress Toward New WHO Goals: Spain, Joaquin Cabezas, MD - Joaquin Cabezas, MD

International Viral Hepatitis Elimination Meeting (IVHEM) 2021

Epidemiology of HIV and viral hepatitis in European countries- Marharyta Shylava

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Treatment issues --- Hepatitis-HIV co-infection- Zahedul Islam

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Management of COVID-19- Akaki Abutidze

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Acute hepatitis- Lali Sharvadze

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

HIV & COVID-19 Coinfection- Prof. Anca Streinu-Cercel

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Liver Disease and COVID-19 Coinfection- Prof. Cihan Yurdaydin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

SARS-COV-2 Vaccines: a Critical Review- Dr. Kathryn Stephenson

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Update on COVID - 19 Therapeutics- Dr. Daniel Kuritzkes

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

HIV Prevention in High Risk Populations: Unique Challenges and Solutions- Dr. Jean-Michel Molina

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Long-Acting Therapy for PrEP: How Will We Use it?- Mr. Luis Mendão

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Update on Guidelines for Preventing MTCT of Hep B- Dr. Philippa Easterbrook

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Update on the Use of Generic Drugs for HIV in Europe- Ms. Liudmyla Maistat

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Implementation of Integrase Inhibitors for First Line Therapy in the CEE Region: How Far Are We?- Prof. Milosz Parczewski

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

EASL Guidelines on Viral Hepatitis Elimination- Prof. Mojca Matičič

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

The Georgian Model for Hepatitis C Elimination (With Reflection on the Impact of COVID-19 Pandemic)- Prof. Nicole Seguy

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

A Phase 3, Open-label, Dose Escalation study to determine the pharmacokinetics of Atazanavir administered with RIfampicin to HIV positive adults on sEcond-line ART regimen with suppressed HIV-1 viral load (DERIVE): Scheduled Interim Analysis

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020

Drug-Drug Interactions in Hospitalized COVID-19 Patients Receiving Investigational Drugs (CATCO-DDI)

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020

Low-level viremia is associated with lower cumulative adherence to antiretroviral therapy in persons with HIV

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Using PBPK modelling to estimate lamivudine exposure in children with abnormal kidney function

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Charles Boucher Memorial Lecture

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021